SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001683168-19-003503
Filing Date
2019-11-08
Accepted
2019-11-08 16:25:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS cns_424b4.htm 424B4 1067962
  Complete submission text file 0001683168-19-003503.txt   1068956
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-232443 | Film No.: 191204388
SIC: 2834 Pharmaceutical Preparations